Use of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: A pharmacokinetic study-Reference-Cited by-同舟云学术

Use of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: A pharmacokinetic study

Published:1994-06 Issue:3 Volume:29 Page:541-543
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Shulman Lawrence N.,Buswell Lori,Kalish Leslie A.,Norman Coleman C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference12 articles.

1. Identification of a hypoxic population of bone marrow cells;Allalunis;Int. J. Radiat. Oncol. Biol. Phys.,1983

2. Chemical modifiers of cancer treatment;Coleman;J. Clin. Oncol.,1988

3. Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole;Coleman;Cancer Res.,1988

4. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR 2508;Coleman;Int. J. Radiat. Oncol. Biol. Phys.,1984

5. Initial pharmacology and toxicology of intravenous desmethylmisonidazole;Coleman;Int. J. Radiat. Oncol. Biol. Phys.,1982

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porphyrin- and Expanded Porphyrin-Based Diagnostic and Therapeutic Agents;Perspectives in Supramolecular Chemistry;2007-03-12

2. One-Electron Reduction and Oxidation Studies of the Radiation Sensitizer Gadolinium(III) Texaphyrin (PCI-0120) and Other Water Soluble Metallotexaphyrins;The Journal of Physical Chemistry A;1999-02-01

3. Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide±hepatic enzyme effectors;Cancer Chemotherapy and Pharmacology;1996-09-12